Skip to main content
BMC Complementary Medicine and Therapies logoLink to BMC Complementary Medicine and Therapies
. 2023 Mar 4;23:68. doi: 10.1186/s12906-023-03865-5

Correction: Protective effects of Xinji′erkang on myocardial infarction induced cardiac injury in mice

Juan Hu 1,#, Yong-xue Zhang 1,#, Li Wang 1, Ling Ding 1, Guang-yao Huang 1, Guo-wei Cai 1, Shan Gao 1,
PMCID: PMC9985275  PMID: 36869324

Correction: BMC Complement Med Ther 17, 338 (2017)

https://doi.org/10.1186/s12906-017-1846-5

Following publication of the original article [1], the authors identified an error in Fig. 3. The b4 of Fig. 3 in this published paper was wrongly used. The correct figure is given below.

Fig. 3.

Fig. 3

Effect of XJEK on cardiomyocyte CSA and cardiomyocyte long axis of MI mice (HE stain, magnification×400). a Representative images of histological section of cardiomyocyte cross-section (HE staining, magnification×400); b Representative images of histological section of cardiomyocyte long axis (HE staining, magnification×400); c Quantitative analyses results (mean ± SEM, n=6–9). (1) Sham group; (2) Model group; (3) XJEK group; (4) Fosinopril group. * P<0.05, ** P<0.01 vs. Sham group; #P<0.05, ##P<0.01 vs. Model group

The original article [1] has been corrected.

Footnotes

Juan Hu and Yong-xue Zhang contributed equally to this work.

Reference

  • 1.Hu J, Zhang Y, Wang L, et al. Protective effects of Xinji′erkang on myocardial infarction induced cardiac injury in mice. BMC Complement Altern Med. 2017;17:338. doi: 10.1186/s12906-017-1846-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Complementary Medicine and Therapies are provided here courtesy of BMC

RESOURCES